Position in INCY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$60,534
+$11,969 QoQ
Shares Held
534
+3.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#694
of 854 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cromwell Holdings LLC holds $957,383 across 23 Biotechnology names. INCY ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
664 | $329,828 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
342 | $213,250 | |
| 3 | ARGX |
Argenx SE
|
187 | $173,492 | |
| 4 | MRNA |
Moderna, Inc.
|
1,259 | $88,167 | |
| 5 | INCY |
Incyte Corp
This page
|
534 | $60,534 | |
| 6 | GMAB |
Genmab A/S
|
1,077 | $29,585 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
43 | $12,944 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
41 | $7,678 |
All Filings in INCY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,534 | 534 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $48,565 | 516 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $50,964 | 516 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $43,761 | 516 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $35,138 | 516 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $34,815 | 575 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $38,886 | 563 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $37,214 | 563 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $16,973 | 280 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||